Latest headcount
17,000
YoY change
-3.4%
Headcount CAGR
+12.7%
Revenue / employee
$1.73M
Employee count history for Gilead Sciences
| Fiscal year | Employees |
|---|---|
| 2000 | 850 |
| 2001 | 1,000 |
| 2002 | 1,250 |
| 2003 | 1,425 |
| 2004 | 1,654 |
| 2005 | 1,900 |
| 2006 | 2,515 |
| 2007 | 2,979 |
| 2008 | 3,441 |
| 2009 | 3,852 |
| 2010 | 4,000 |
| 2011 | 4,500 |
| 2012 | 5,000 |
| 2013 | 6,100 |
| 2014 | 7,000 |
| 2015 | 8,000 |
| 2016 | 9,000 |
| 2017 | 10,000 |
| 2018 | 11,000 |
| 2019 | 11,800 |
| 2020 | 13,600 |
| 2021 | 14,400 |
| 2022 | 17,000 |
| 2023 | 18,000 |
| 2024 | 17,600 |
| 2025 | 17,000 |
Revenue per employee for Gilead Sciences
Annual revenue divided by reported headcount, normalized to US dollars.
| Fiscal year | Revenue per employee (USD) |
|---|---|
| 2000 | $230K |
| 2001 | $234K |
| 2002 | $373K |
| 2003 | $609K |
| 2004 | $801K |
| 2005 | $1.07M |
| 2006 | $1.2M |
| 2007 | $1.42M |
| 2008 | $1.55M |
| 2009 | $1.82M |
| 2010 | $1.99M |
| 2011 | $1.86M |
| 2012 | $1.94M |
| 2013 | $1.84M |
| 2014 | $3.56M |
| 2015 | $4.08M |
| 2016 | $3.38M |
| 2017 | $2.61M |
| 2018 | $2.01M |
| 2019 | $1.9M |
| 2020 | $1.82M |
| 2021 | $1.9M |
| 2022 | $1.6M |
| 2023 | $1.51M |
| 2024 | $1.63M |
| 2025 | $1.73M |
Earnings per employee for Gilead Sciences
Annual net income divided by reported headcount, normalized to US dollars; years with a net loss dip below zero.
| Fiscal year | Earnings per employee (USD) |
|---|---|
| 2000 | -$66.8K |
| 2001 | $52.3K |
| 2002 | $57.7K |
| 2003 | -$50.5K |
| 2004 | $272K |
| 2005 | $428K |
| 2006 | -$473K |
| 2007 | $542K |
| 2008 | $575K |
| 2009 | $684K |
| 2010 | $725K |
| 2011 | $623K |
| 2012 | $518K |
| 2013 | $504K |
| 2014 | $1.73M |
| 2015 | $2.26M |
| 2016 | $1.5M |
| 2017 | $463K |
| 2018 | $496K |
| 2019 | $456K |
| 2020 | $9.04K |
| 2021 | $432K |
| 2022 | $270K |
| 2023 | $315K |
| 2024 | $27.3K |
| 2025 | $501K |
Employee count history for Gilead Sciences (GILD)
Annual figures come from annual reports (10-K, or 20-F/40-F for foreign filers); interim rows reflect headcount disclosed in periodic filings. Year-over-year change compares each filing with the prior year's equivalent. Revenue and earnings per employee are annual figures normalized to US dollars.
- 202517,000-3.4%
- 202417,600-2.2%
- 202318,000+5.9%
- 202217,000+18.1%
- 202114,400+5.9%
- 202013,600+15.3%
- 201911,800+7.3%
- 201811,000+10.0%
- 201710,000+11.1%
- 20169,000+12.5%
- 20158,000+14.3%
- 20147,000+14.8%
- 20136,100+22.0%
- 20125,000+11.1%
- 20114,500+12.5%
- 20104,000+3.8%
- 20093,852+11.9%
- 20083,441+15.5%
- 20072,979+18.4%
- 20062,515+32.4%
- 20051,900+14.9%
- 20041,654+16.1%
- 20031,425+14.0%
- 20021,250+25.0%
- 20011,000+17.6%
- 2000850—
- 1999760+159.4%
- 1998293+1.4%
- 1997289+16.5%
- 1996248—
About Gilead Sciences's employee count
Gilead Sciences (GILD) employed 17,000 people in fiscal year 2025, based on its most recent annual report. That headcount shrank by -600 (-3.4%) from 17,600 a year earlier.
Across the 2000–2025 period, the company's reported workforce went from 850 to 17,000 employees — a compound annual growth rate (CAGR) of +12.7% per year.
Gilead Sciences generated about $1.73M of revenue and $501K of net income per employee in its latest annual period. Revenue and earnings per employee gauge how efficiently a company turns headcount into output, and are most telling when tracked over time or compared with peers in the same industry.
Frequently asked questions
Test yourself on GILD
Employees — 10 rounds, every one of them GILD against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks0.93% TTM
- Dividend Profile2.47% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History5 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.